T1	Participants 108 182	outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV
T2	Participants 324 366	patients with cardiovascular disease (CVD)
T3	Participants 480 535	community pharmacist interventions in patients with CVD
T4	Participants 729 839	patients with CVD and/or high or intermediate cardiovascular (CV) risk attending community pharmacies in Spain
T5	Participants 849 985	Patients aged 25 to 74 years attending community pharmacies with a prescription for at least 1 drug indicated for CVD or CV risk factors
T6	Participants 1303 1363	Patients were recruited from December 2005 to September 2006
T7	Participants 3203 3297	patients with CVD and/or high or intermediate CV risk attending community pharmacies in Spain.
